Parallel Arm Trial of AD109 and AD504 In Patients With OSA (MARIPOSA)

  • STATUS
    Not Recruiting
  • day left to enroll
    1
  • participants needed
    280
  • sponsor
    Apnimed
Updated on 27 June 2022

Summary

This is a phase 2 randomized double-blind placebo-controlled parallel-arm dose finding study to compare fixed dose combinations of AD109 and AD504 to atomoxetine or placebo in Obstructive Sleep Apnea.

Details
Condition OSA - Obstructive Sleep Apnea
Treatment Placebo, atomoxetine hydrochloride, AD109, AD504
Clinical Study IdentifierNCT05071612
SponsorApnimed
Last Modified on27 June 2022

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note